79Indexed trials
Market Rank #27 · Evidence Tier A
Portugal
Neuroscience Intelligence
Portugal neuroscience intelligence: 79 indexed trials, 16 institutions, research score 29.96.
27Recruiting
16Research institutions
30.0Research score
Evidence profile
49Sponsors
17Disease areas
0Institution works
0Institution citations
Model signals
Opportunity 30 · ML priority 30 · Confidence 85 · Evidence 30.0
These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.
Leading disease areas
alzheimers15trials
parkinsons13trials
epilepsy11trials
multiple_sclerosis7trials
stroke3trials
schizophrenia3trials
autism3trials
migraine_headache3trials
other_psychiatry2trials
huntingtons2trials
Leading indexed sponsors
Hoffmann-La Roche9trials
Bial - Portela C S.A.9trials
AbbVie3trials
University of Coimbra3trials
Novo Nordisk A/S3trials
Merck Sharp & Dohme LLC3trials
Bayer2trials
GlaxoSmithKline2trials
Boehringer Ingelheim2trials
Celgene2trials